Aigen Investment Management LP lessened its holdings in Amdocs Limited (NASDAQ:DOX – Free Report) by 65.2% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 4,443 shares of the technology company’s stock after selling 8,340 shares during the period. Aigen Investment Management LP’s holdings in Amdocs were worth $389,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also bought and sold shares of DOX. Catalyst Capital Advisors LLC purchased a new stake in shares of Amdocs during the third quarter worth about $55,000. GAMMA Investing LLC boosted its stake in Amdocs by 115.1% in the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after purchasing an additional 428 shares during the period. American National Bank purchased a new stake in Amdocs during the 2nd quarter valued at approximately $76,000. Blue Trust Inc. raised its position in shares of Amdocs by 18.0% during the second quarter. Blue Trust Inc. now owns 1,138 shares of the technology company’s stock valued at $90,000 after buying an additional 174 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Amdocs by 24.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,215 shares of the technology company’s stock worth $175,000 after buying an additional 440 shares in the last quarter. 92.02% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of analysts have issued reports on DOX shares. Barclays reduced their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday. Stifel Nicolaus began coverage on Amdocs in a report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price on the stock. StockNews.com lowered Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Finally, Oppenheimer lifted their price objective on Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Amdocs has a consensus rating of “Moderate Buy” and a consensus price target of $101.83.
Amdocs Price Performance
NASDAQ:DOX opened at $85.71 on Friday. The firm has a market capitalization of $10.07 billion, a price-to-earnings ratio of 20.21, a PEG ratio of 1.50 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24. The business has a 50 day simple moving average of $88.18 and a 200-day simple moving average of $83.94. Amdocs Limited has a 1 year low of $74.41 and a 1 year high of $94.04.
Amdocs Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a yield of 2.24%. The ex-dividend date is Tuesday, December 31st. Amdocs’s payout ratio is 45.28%.
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
- Five stocks we like better than Amdocs
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- What Investors Need to Know About Upcoming IPOs
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- ESG Stocks, What Investors Should Know
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.